|
INSULET Corporation (PODD) Avaliação DCF
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Insulet Corporation (PODD) Bundle
Procurando avaliar o valor intrínseco da INSULET Corporation? Nossa calculadora DCF (PODD) integra dados do mundo real com extensos recursos de personalização, permitindo refinar suas previsões e aprimorar suas estratégias de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 904.4 | 1,098.8 | 1,305.3 | 1,697.1 | 2,071.6 | 2,550.0 | 3,138.9 | 3,863.7 | 4,755.9 | 5,854.2 |
| Revenue Growth, % | 0 | 21.49 | 18.79 | 30.02 | 22.07 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 |
| EBITDA | 110.3 | 139.6 | 109.5 | 323.6 | 423.7 | 371.3 | 457.1 | 562.6 | 692.6 | 852.5 |
| EBITDA, % | 12.2 | 12.7 | 8.39 | 19.07 | 20.45 | 14.56 | 14.56 | 14.56 | 14.56 | 14.56 |
| Depreciation | 55.4 | 57.4 | 63.2 | 72.8 | 80.8 | 124.3 | 153.1 | 188.4 | 231.9 | 285.5 |
| Depreciation, % | 6.13 | 5.22 | 4.84 | 4.29 | 3.9 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 |
| EBIT | 54.9 | 82.2 | 46.3 | 250.8 | 342.9 | 247.0 | 304.0 | 374.2 | 460.7 | 567.0 |
| EBIT, % | 6.07 | 7.48 | 3.55 | 14.78 | 16.55 | 9.69 | 9.69 | 9.69 | 9.69 | 9.69 |
| Total Cash | 947.6 | 791.6 | 674.7 | 704.2 | 953.4 | 1,587.4 | 1,953.9 | 2,405.1 | 2,960.6 | 3,644.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 83.8 | 161.0 | 205.6 | 359.7 | 365.5 | 400.4 | 492.8 | 606.7 | 746.8 | 919.2 |
| Account Receivables, % | 9.27 | 14.65 | 15.75 | 21.19 | 17.64 | 15.7 | 15.7 | 15.7 | 15.7 | 15.7 |
| Inventories | 154.3 | 303.2 | 346.8 | 402.6 | 430.4 | 590.2 | 726.5 | 894.2 | 1,100.7 | 1,354.9 |
| Inventories, % | 17.06 | 27.59 | 26.57 | 23.72 | 20.78 | 23.14 | 23.14 | 23.14 | 23.14 | 23.14 |
| Accounts Payable | 54.1 | 37.7 | 30.8 | 19.2 | 19.8 | 70.7 | 87.0 | 107.1 | 131.8 | 162.3 |
| Accounts Payable, % | 5.98 | 3.43 | 2.36 | 1.13 | 0.95578 | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 |
| Capital Expenditure | -166.5 | -122.7 | -157.3 | -75.6 | -124.9 | -265.8 | -327.1 | -402.7 | -495.7 | -610.1 |
| Capital Expenditure, % | -18.41 | -11.17 | -12.05 | -4.45 | -6.03 | -10.42 | -10.42 | -10.42 | -10.42 | -10.42 |
| Tax Rate, % | -39.34 | -39.34 | -39.34 | -39.34 | -39.34 | -39.34 | -39.34 | -39.34 | -39.34 | -39.34 |
| EBITAT | 38.5 | 67.4 | 21.7 | 241.1 | 477.8 | 195.2 | 240.3 | 295.7 | 364.0 | 448.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -256.6 | -240.4 | -167.5 | 16.8 | 400.7 | -90.0 | -146.3 | -180.0 | -221.6 | -272.8 |
| WACC, % | 9.96 | 9.98 | 9.91 | 10.01 | 10.02 | 9.98 | 9.98 | 9.98 | 9.98 | 9.98 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -659.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -278 | |||||||||
| Terminal Value | -3,488 | |||||||||
| Present Terminal Value | -2,168 | |||||||||
| Enterprise Value | -2,828 | |||||||||
| Net Debt | -870 | |||||||||
| Equity Value | -1,958 | |||||||||
| Diluted Shares Outstanding, MM | 74 | |||||||||
| Equity Value Per Share | -26.50 |
What You Will Get
- Real Insulet Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Insulet’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- 🔍 Real-Life PODD Financials: Pre-filled historical and projected data for Insulet Corporation.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Insulet’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Insulet’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download the Template: Get instant access to the Excel-based Insulet Corporation (PODD) DCF Calculator.
- Input Your Assumptions: Adjust yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically updates Insulet’s intrinsic value.
- Test Scenarios: Simulate different assumptions to evaluate potential valuation changes.
- Analyze and Decide: Use the results to guide your investment or financial analysis.
Why Choose Insulet Corporation (PODD)?
- Innovative Technology: Cutting-edge insulin delivery systems designed for convenience and efficiency.
- Enhanced Patient Experience: User-friendly devices that improve the quality of life for individuals with diabetes.
- Strong Market Presence: A leader in the diabetes management sector with a proven track record.
- Commitment to Research: Ongoing investment in development to provide the latest advancements in diabetes care.
- Endorsed by Healthcare Professionals: Trusted by clinicians for its reliability and effectiveness in patient management.
Who Should Use Insulet Corporation (PODD)?
- Healthcare Professionals: Understand the latest advancements in insulin delivery systems and their impact on patient care.
- Researchers: Utilize cutting-edge data for studies on diabetes management and technology integration.
- Investors: Evaluate investment opportunities by analyzing the performance and market potential of Insulet Corporation (PODD).
- Analysts: Enhance your analysis with a comprehensive overview of Insulet's financial health and growth prospects.
- Diabetes Educators: Stay informed about innovative products and their benefits for patients managing diabetes.
What the Template Contains
- Pre-Filled DCF Model: Insulet Corporation’s (PODD) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Insulet Corporation’s (PODD) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.